Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SNSS
FechaHoraFuenteTítuloSímboloCompañía
09/06/202317:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/05/202315:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/05/202315:53Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
27/04/202315:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
27/04/202315:09Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
14/03/202316:14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
14/02/202305:03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/01/202316:22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/11/202215:38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
19/09/202217:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/07/202215:58Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
27/06/202215:37Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/12/202105:08Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:SNSSSunesis Pharmaceuticals Inc
16/02/202115:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SNSSSunesis Pharmaceuticals Inc
15/01/202105:24Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SNSSSunesis Pharmaceuticals Inc
14/01/202116:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
13/01/202105:03Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
16/11/202015:05GlobeNewswire Inc.Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
09/11/202006:00GlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent H...NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/10/202006:00GlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular ...NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/09/202006:00GlobeNewswire Inc.Sunesis Pharmaceuticals Announces Participation at Upcoming Investor ConferencesNASDAQ:SNSSSunesis Pharmaceuticals Inc
02/09/202011:48GlobeNewswire Inc.Sunesis Pharmaceuticals Announces 1-for-10 Reverse Stock SplitNASDAQ:SNSSSunesis Pharmaceuticals Inc
11/08/202015:05GlobeNewswire Inc.Sunesis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
04/08/202006:00GlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on August 11th to Discuss Second Quarter 2020 Financial Results and Recent Hi...NASDAQ:SNSSSunesis Pharmaceuticals Inc
30/07/202017:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
29/07/202008:05GlobeNewswire Inc.Sunesis Announces Pricing of $12 Million Offering of Common StockNASDAQ:SNSSSunesis Pharmaceuticals Inc
28/07/202015:07GlobeNewswire Inc.Sunesis Announces Proposed Public Offering of Common StockNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/07/202015:01GlobeNewswire Inc.Sunesis Pharmaceuticals Provides Corporate UpdateNASDAQ:SNSSSunesis Pharmaceuticals Inc
23/06/202006:30GlobeNewswire Inc.Sunesis Pharmaceuticals Announces Clinical Update on Vecabrutinib ProgramNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/05/202015:05GlobeNewswire Inc.Sunesis Pharmaceuticals Reports First Quarter 2020 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNSS

Su Consulta Reciente

Delayed Upgrade Clock